Atul Ltd 2020-21

113 Statutory Report 22 - 87 Financial Statements 88 - 229 Corporate Overview 01 - 21 S hort-term employee benefits are provided at undiscounted amount during the accounting period based on service rendered by employees. iv) Other long-term employee benefits T he liabilities for earned leave and sick leave are not expected to be settled wholly within 12 months after the end of the period in which the employees render the related service. They are therefore measured as the present value of expected future payments to be made in respect of services provided by employees up to the end of the reporting period using the projected unit credit method. The benefits are discounted using the market yields at the end of the reporting period that have terms approximating to the terms of the related obligation. Remeasurements as a result of experience adjustments and changes in actuarial assumptions are recognised in profit or loss. x) Research and Development expenditure Expenditure on research is recognised as an expense when it is incurred. Expenditure on development which does not meet the criteria for recognition as an intangible asset is recognised as an expense when it is incurred. Items of property, plant and equipment and acquired intangible assets utilised for research and development are capitalised and depreciated in accordance with the policies stated for property, plant and equipment and intangible assets. y) Earnings per share Earnings per share (EPS) is calculated by dividing the net profit or loss for the period attributable to equity shareholders by the weighted average number of equity shares outstanding during the period. For the purpose of calculating diluted EPS, the net profit for the period attributable to equity shareholders and the weighted average number of equity shares outstanding during the period are adjusted for the effects of all dilutive potential equity shares. z) Ordinary shares Ordinary shares are classified as equity share capital. Incremental costs directly attributable to the issuance of new ordinary shares, share options and buy-back are recognised as a deduction from equity, net of any tax effects. Estimation of uncertainties relating to the COVID-19 pandemic The manufacturing facilities of the Company that were shutdown in the last week of March 2020 due to the countrywide lockdown, resumed operations in a phased manner from the last week of April 2020 after obtaining the requisite approvals. The Company has considered possible effects that may result from the COVID-19 pandemic in preparation of these Standalone Financial Statements, including recoverability of inventories, trade receivables and other assets. In developing the assumptions relating to future uncertainties in the economic conditions due to the COVID-19 pandemic, it has, at the date of approval of these Standalone Financial Statements, used relevant internal and external sources of information, including economic forecasts and expects that the carrying amounts of these assets are recoverable. The impact of the COVID-19 pandemic, including the current wave, may be different from that estimated as at the date of approval of these Standalone Financial Statements. Critical estimates and judgements Preparation of the Standalone Financial Statements require use of accounting estimates, judgements and assumptions, which, by definition, will seldom equal the actual results. Appropriate changes in estimates are made as the Management becomes aware of changes in circumstances surrounding the estimates. Changes in estimates are reflected in the Standalone Financial Statements in the period in which changes are made and, if material, their effects are disclosed in the notes to the Standalone Financial Statements. This Note provides an overview of the areas that involve a higher degree of judgements or complexity and of items that are more likely to be materially adjusted due to estimates and assumptions turning out to be different than those originally assessed. Detailed information about each of these estimates and judgements is included in relevant notes together with information about the basis of calculation for each affected line item in the Standalone Financial Statements. The areas involving critical estimates or judgements are: i) Estimation for income tax: Note 1 (e) ii) Estimation of useful life of tangible assets: Note 1 (h) iii) Estimation of provision for inventories: Note 1 (o) iv) Allowance for credit losses on trade receivables: Note 1 (m) v) Estimation of claims | liabilities: Note 1 (v) vi) Estimation of defined benefit obligations: Note 1 (w) vii) Fair value measurements: Note 28.7 viii) Impairment: Note 1 (k)